Sumoylation of p68 and p72 RNA helicases affects protein stability and transactivation potential

Biochemistry

Volumn 49, Issue 1, 2010, Pages 1-10

  Mooney, Steven M ^a   Grande, Joseph P ^a   Salisbury, Jeffrey L ^a   Janknecht, Ralf ^a,b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; BREAST TUMOR; CO-ACTIVATION; COACTIVATORS; ESTROGEN RECEPTOR; ESTROGEN RESPONSE ELEMENTS; HISTONE DEACETYLASES; OVER-EXPRESSION; PLEIOTROPIC EFFECTS; POLYUBIQUITYLATION; PROTEASOMAL DEGRADATION; PROTEIN STABILITY; RNA HELICASES; SUMOYLATION; TRANSACTIVATION; TUMORIGENESIS;

BIOINFORMATICS; ONCOLOGY; RADIOACTIVITY; RNA; TRANSCRIPTION; TUMORS;

PROTEINS;

ESTROGEN RECEPTOR; HISTONE DEACETYLASE; HISTONE DEACETYLASE 2; HISTONE DEACETYLASE 3; PROTEIN MDM2; PROTEIN P68; PROTEIN P72; RNA HELICASE;

ARTICLE; BIOINFORMATICS; BREAST CANCER; CARCINOGENESIS; CONSENSUS; ENZYME BINDING; ENZYME DEGRADATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MUTANT; MUTATION; PLEIOTROPY; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN STABILITY; SUMOYLATION; TRANSACTIVATION; UPREGULATION;

BINDING SITES; BREAST NEOPLASMS; CARRIER PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; DEAD-BOX RNA HELICASES; FEMALE; HUMANS; PROTEIN STABILITY; RECEPTORS, ESTROGEN; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 73449119972     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi901263m     Document Type: Article

References (67)

1. Bleichert, F., and Baserga, S. J. (2007) The long unwinding road of RNA helicases. Mol. Cell 27, 339-352.
2. Rocak, S., and Linder, P. (2004) DEAD-box proteins: the driving forces behind RNA metabolism. Nat. Rev. Mol. Cell Biol. 5, 232-241.
3. Fukuda, T., Yamagata, K., Fujiyama, S., Matsumoto, T., Koshida, I., Yoshimura, K., Mihara, M., Naitou, M., Endoh, H., Nakamura, T., Akimoto, C., Yamamoto, Y., Katagiri, T., Foulds, C., Takezawa, S., Kitagawa, H., Takeyama,K., O'Malley, B. W., and Kato, S. (2007) DEAD-box RNA helicase subunits of the Drosha complex are required for processing of rRNA and a subset of microRNAs. Nat. Cell Biol. 9, 604-611.
4. Fuller-Pace, F. V. (2006) DExD/H box RNA helicases: multifunctional proteins with important roles in transcriptional regulation. Nucleic Acids Res. 34, 4206-4215.
5. Endoh, H., Maruyama, K., Masuhiro, Y., Kobayashi, Y., Goto, M., Tai, H., Yanagisawa, J., Metzger, D., Hashimoto, S., and Kato, S. (1999) Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha. Mol. Cell. Biol. 19, 5363-5372.
6. Watanabe, M., Yanagisawa, J., Kitagawa, H., Takeyama, K., Ogawa, S., Arao, Y., Suzawa, M., Kobayashi, Y., Yano, T., Yoshikawa, H., Masuhiro, Y., and Kato, S. (2001) A subfamily of RNA-binding DEAD-box proteins acts as an estrogen receptor alpha coactivator through the N-terminal activation domain (AF-1) with an RNA coactivator, SRA. EMBO J. 20, 1341-1352.
7. Clark, E. L., Coulson, A., Dalgliesh, C., Rajan, P., Nicol, S. M., Fleming, S., Heer, R., Gaughan, L., Leung, H. Y., Elliott, D. J., Fuller-Pace, F. V., and Robson, C. N. (2008) TheRNAhelicase p68 is a novel androgen receptor coactivator involved in splicing and is overexpressed in prostate cancer. Cancer Res. 68, 7938-7946.
8. Bates,G. J., Nicol, S.M.,Wilson, B. J., Jacobs, A.M., Bourdon, J. C., Wardrop, J.,Gregory,D. J., Lane,D. P., Perkins, N. D., and Fuller-Pace, F. V. (2005) The DEAD box protein p68: a novel transcriptional coactivator of the p53 tumour suppressor. EMBO J. 24, 543-553.
9. Caretti, G., Schiltz, R. L., Dilworth, F. J., Di Padova, M., Zhao, P., Ogryzko, V., Fuller-Pace, F. V., Hoffman, E. P., Tapscott, S. J., and Sartorelli, V. (2006) The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. Dev. Cell 11, 547-560.
10. Jensen, E. D., Niu, L., Caretti, G., Nicol, S. M., Teplyuk, N., Stein, G. S., Sartorelli, V., van Wijnen, A. J., Fuller-Pace, F. V., and Westendorf, J. J. (2008) p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation. J. Cell. Biochem. 103, 1438-1451.
11. Rossow, K. L., and Janknecht, R. (2003) Synergism between p68 RNA helicase and the transcriptional coactivators CBP and p300. Oncogene 22, 151-156.
12. Shin, S., and Janknecht, R. (2007) Concerted activation of the Mdm2 promoter by p72RNAhelicase and the coactivators p300 and P/CAF. J. Cell. Biochem. 101, 1252-1265.
13. Yang, L., Lin, C., Zhao, S., Wang, H., and Liu, Z. R. (2007) Phosphorylation of p68 RNA helicase plays a role in platelet-derived growth factor-induced cell proliferation by up-regulating cyclin D1 and c-Myc expression. J. Biol. Chem. 282, 16811-16819.
14. Shin, S., Rossow, K. L., Grande, J. P., and Janknecht, R. (2007) Involvement of RNA helicases p68 and p72 in colon cancer. Cancer Res. 67, 7572-7578.
15. Yang, L., Lin, C., and Liu, Z. R. (2006) P68 RNA helicase mediates PDGF-induced epithelial mesenchymal transition by displacing axin from beta-catenin. Cell 127, 139-155.
16. Causevic, M., Hislop, R. G., Kernohan, N. M., Carey, F. A., Kay, R. A., Steele, R. J., and Fuller-Pace, F. V. (2001) Overexpression and poly-ubiquitylation of theDEAD-boxRNAhelicase p68 in colorectal tumours. Oncogene 20, 7734-7743.
17. Johnson, E. S. (2004) Protein modification by SUMO. Annu. Rev. Biochem. 73, 355-382.
18. Geiss-Friedlander, R., and Melchior, F. (2007) Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8, 947-956.
19. Girdwood, D. W., Tatham, M. H., and Hay, R. T. (2004) SUMO and transcriptional regulation. Semin. Cell Dev. Biol. 15, 201-210.
20. Gostissa, M., Hengstermann, A., Fogal, V., Sandy, P., Schwarz, S. E., Scheffner, M., and Del Sal, G. (1999) Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1. EMBO J. 18, 6462-6471.
21. Rodriguez, M. S., Desterro, J. M., Lain, S., Midgley, C. A., Lane, D. P., and Hay, R. T. (1999) SUMO-1 modification activates the transcriptional response of p53. EMBO J. 18, 6455-6461.
22. Goodson, M. L., Hong, Y., Rogers, R., Matunis, M. J., Park-Sarge, O. K., and Sarge, K. D. (2001) Sumo-1 modification regulates the DNA binding activity of heat shock transcription factor 2, a promyelocytic leukemia nuclear body associated transcription factor. J. Biol. Chem. 276, 18513-18518.
23. Hong, Y., Rogers, R., Matunis, M. J., Mayhew, C. N., Goodson, M. L., Park-Sarge, O. K., and Sarge, K. D. (2001) Regulation of heat shock transcription factor 1 by stress-induced SUMO-1 modification. J. Biol. Chem. 276, 40263-40267.
24. Chauchereau, A., Amazit, L., Quesne, M., Guiochon-Mantel, A., and Milgrom, E. (2003) Sumoylation of the progesterone receptor and of the steroid receptor coactivator SRC-1. J. Biol. Chem. 278, 12335-12343.
25. Sentis, S., Le Romancer, M., Bianchin, C., Rostan, M. C., and Corbo, L. (2005) Sumoylation of the estrogen receptor alpha hinge region regulates its transcriptional activity. Mol. Endocrinol. 19, 2671-2684.
26. Fuchs, B., Inwards, C. Y., and Janknecht, R. (2004) Vascular endothelial growth factor expression is up-regulated by EWS-ETS oncoproteins and Sp1 and may represent an independent predictor of survival in Ewing's sarcoma. Clin. Cancer Res. 10, 1344-1353.
27. Kim, T. D., Shin, S., and Janknecht, R. (2008) Repression of Smad3 activity by histone demethylase SMCX/JARID1C. Biochem. Biophys. Res. Commun. 366, 563-567.
28. Shin, S., and Janknecht, R. (2007) Activation of androgen receptor by histone demethylases JMJD2A and JMJD2D. Biochem. Biophys. Res. Commun. 359, 742-746.
29. Bosc, D. G., Goueli, B. S., and Janknecht, R. (2001) HER2/Neu-mediated activation of the ETS transcription factor ER81 and its target gene MMP-1. Oncogene 20, 6215-6224.
30. Janknecht, R. (2003) Regulation of the ER81 transcription factor and its coactivators by mitogen- and stress-activated protein kinase 1 (MSK1). Oncogene 22, 746-755.
31. Goel, A., and Janknecht, R. (2003) Acetylation-mediated transcriptional activation of the ETS protein ER81 by p300, P/CAF, and HER2/Neu. Mol. Cell. Biol. 23, 6243-6254.
32. Papoutsopoulou, S., and Janknecht, R. (2000) Phosphorylation of ETS transcription factor ER81 in a complex with its coactivators CREB-binding protein and p300. Mol. Cell. Biol. 20, 7300-7310.
33. Shin, S., and Janknecht,R. (2007) Diversity within the JMJD2 histone demethylase family. Biochem. Biophys. Res. Commun. 353, 973-977.
34. Goueli, B. S., and Janknecht, R. (2003) Regulation of telomerase reverse transcriptase gene activity by upstream stimulatory factor. Oncogene 22, 8042-8047.
35. Goel, A., and Janknecht, R. (2004) Concerted activation of ETS protein ER81 by p160 coactivators, the acetyltransferase p300 and the receptor tyrosine kinase HER2/Neu. J. Biol. Chem. 279, 14909-14916.
36. Knebel, J., De Haro, L., and Janknecht, R. (2006) Repression of transcription by TSGA/Jmjd1a, a novel interaction partner of the ETS protein ER71. J. Cell. Biochem. 99, 319-329.
37. Rossow, K. L., and Janknecht, R. (2001) The Ewing's sarcoma gene product functions as a transcriptional activator. Cancer Res. 61, 2690-2695.
38. Janknecht, R. (2001) Cell type-specific inhibition of the ETS transcription factor ER81 by mitogen-activated protein kinase-activated protein kinase 2. J. Biol. Chem. 276, 41856-41861.
39. Shin, S., Bosc, D. G., Ingle, J. N., Spelsberg, T. C., and Janknecht, R. (2008) Rcl is a novel ETV1/ER81 target gene upregulated in breast tumors. J. Cell. Biochem. 105, 866-874.
40. Bosc, D. G., and Janknecht, R. (2002) Regulation of HER2/Neu promoter activity by the ETS transcription factor, ER81. J. Cell. Biochem. 86, 174-183.
41. Paech, K., Webb, P., Kuiper, G. G., Nilsson, S., Gustafsson, J., Kushner, P. J., and Scanlan, T. S. (1997) Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites. Science 277, 1508-1510.
42. Ries, S., Biederer, C., Woods, D., Shifman, O., Shirasawa, S., Sasazuki, T., McMahon, M., Oren, M., and McCormick, F. (2000) Opposing effects of Ras on p53: transcriptional activation of mdm2 and induction of p19ARF. Cell 103, 321-330.
43. Janknecht, R. (1996) Analysis of the ERK-stimulated ETS transcription factor ER81. Mol. Cell. Biol. 16, 1550-1556.
44. Wu, J., and Janknecht, R. (2002) Regulation of the ETS transcription factor ER81 by the 90-kDa ribosomal S6 kinase 1 and protein kinase A. J. Biol. Chem. 277, 42669-42679.
45. Dowdy, S. C., Mariani, A., and Janknecht, R. (2003) HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81. J. Biol. Chem. 278, 44377-44384.
46. Goueli, B. S., and Janknecht, R. (2004) Upregulation of the catalytic telomerase subunit by the transcription factor ER81 and oncogenic HER2/Neu, Ras, or Raf. Mol. Cell. Biol. 24, 25-35.
47. Janknecht, R., and Hunter, T. (1997) Convergence of MAP kinase pathways on the ternary complex factor Sap-1a. EMBO J. 16, 1620-1627.
48. De Haro, L., and Janknecht, R. (2002) Functional analysis of the transcription factor ER71 and its activation of the matrix metalloproteinase-1 promoter. Nucleic Acids Res. 30, 2972-2979.
49. Kotaja, N., Karvonen, U., Janne, O. A., and Palvimo, J. J. (2002) PIAS proteins modulate transcription factors by functioning as SUMO-1 ligases. Mol. Cell. Biol. 22, 5222-5234.
50. De Haro, L., and Janknecht, R. (2005) Cloning of the murine ER71 gene (Etsrp71) and initial characterization of its promoter. Genomics 85, 493-502.
51. Best, J. L., Ganiatsas, S., Agarwal, S., Changou, A., Salomoni, P., Shirihai, O., Meluh, P. B., Pandolfi, P. P., and Zon, L. I. (2002) SUMO-1 protease-1 regulates gene transcription through PML. Mol. Cell 10, 843-855.
52. Uhlmann-Schiffler, H., R€ossler, O. G., and Stahl, H. (2002) The mRNA of DEAD box protein p72 is alternatively translated into an 82-kDa RNA helicase. J. Biol. Chem. 277, 1066-1075.
53. Wang, L., and Banerjee, S. (2004) Differential PIAS3 expression in human malignancy. Oncol. Rep. 11, 1319-1324.
54. Richardson, A. L., Wang, Z. C., De Nicolo, A., Lu, X., Brown, M., Miron, A., Liao, X., Iglehart, J. D., Livingston, D. M., and Ganesan, S. (2006) X chromosomal abnormalities in basal-like human breast cancer. Cancer Cell 9, 121-132.
55. Jacobs, A. M., Nicol, S. M., Hislop, R. G., Jaffray, E. G., Hay, R. T., and Fuller-Pace, F. V. (2007) SUMO modification of the DEAD box protein p68 modulates its transcriptional activity and promotes its interaction with HDAC1. Oncogene 26, 5866-5876.
56. Ogilvie, V. C., Wilson, B. J., Nicol, S. M., Morrice, N. A., Saunders, L. R., Barber, G. N., and Fuller-Pace, F. V. (2003) The highly related DEAD box RNA helicases p68 and p72 exist as heterodimers in cells. Nucleic Acids Res. 31, 1470-1480.
57. Wilson, B. J., Bates, G. J., Nicol, S. M., Gregory, D. J., Perkins,N. D., and Fuller-Pace, F. V. (2004) The p68 and p72 DEAD box RNA helicases interact with HDAC1 and repress transcription in a promoter-specific manner. BMC Mol. Biol. 5, 11.
58. Yager, J. D., and Davidson, N. E. (2006) Estrogen carcinogenesis in breast cancer. N. Engl. J. Med. 354, 270-282.
59. Normanno, N., Di Maio, M., De Maio, E., De Luca, A., de Matteis, A., Giordano, A., and Perrone, F. (2005) Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer. Endocr. Relat. Cancer 12, 721-747.
60. Mo, Y. Y., Yu, Y., Theodosiou, E., Ee, P. L., and Beck,W. T. (2005) A role for Ubc9 in tumorigenesis. Oncogene 24, 2677-2683.
61. Desterro, J. M., Rodriguez, M. S., and Hay, R. T. (1998) SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation. Mol. Cell 2, 233-239.
62. Buschmann, T., Fuchs, S. Y., Lee, C. G., Pan, Z. Q., and Ronai, Z. (2000) SUMO-1 modification of Mdm2 prevents its self-ubiquitination and increases Mdm2 ability to ubiquitinate p53. Cell 101, 753-762.
63. Bond, G. L., Hu, W., and Levine, A. J. (2005)MDM2is a central node in the p53 pathway: 12 years and counting. Curr. Cancer Drug Targets 5, 3-8.
64. Lacroix, M., Toillon, R. A., and Leclercq, G. (2006) p53 and breast cancer, an update. Endocr. Relat. Cancer 13, 293-325.
65. Hay, R. T. (2005) SUMO: a history of modification. Mol. Cell 18, 1-12.
66. Nusinzon, I., and Horvath, C. M. (2003) Interferon-stimulated transcription and innate antiviral immunity require deacetylase activity and histone deacetylase 1. Proc. Natl. Acad. Sci. U.S.A. 100, 14742-14747.
67. Zupkovitz, G., Tischler, J., Posch,M., Sadzak, I., Ramsauer, K., Egger, G., Grausenburger, R., Schweifer, N., Chiocca, S., Decker, T., and Seiser, C. (2006) Negative and positive regulation of gene expression by mouse histone deacetylase 1. Mol. Cell. Biol. 26, 7913-7928.